Platinum nanoparticles labelled with iodine-125 for combined “chemo-Auger electron” therapy of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Platinum nanoparticles labelled with iodine-125 for combined “chemo-Auger electron” therapy of hepatocellular carcinoma

Published:2023 Issue:12 Volume:5 Page:3293-3303
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Wawrowicz Kamil¹^ORCID,Żelechowska-Matysiak Kinga¹^ORCID,Majkowska-Pilip Agnieszka¹²^ORCID,Wierzbicki Mateusz³^ORCID,Bilewicz Aleksander¹^ORCID

Affiliation:

1. Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16 St., 03-195 Warsaw, Poland

2. Department of Nuclear Medicine, Central Clinical Hospital of the Ministry of the Interior and Administration, Wołoska 137 St., 02-507 Warsaw, Poland

3. Department of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences, Ciszewskiego 8 St., 02-786 Warsaw, Poland

Abstract

Here we present for the first time iodine-125 labeled platinum nanoparticles targeting the tumor microenvironment for combined “chemo-Auger electron” therapy of hepatocellular carcinoma.

Funder

Narodowe Centrum Nauki

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Materials Science,General Chemistry,Atomic and Molecular Physics, and Optics,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NA/D3NA00165B

Reference61 articles.

1. Targeting metastasis

2. Targeted Alpha Therapy, an Emerging Class of Cancer Agents

3. 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer